US$ 23.76
new glp 1 drugs in development Agonist Clinical Trial Pipeline Appears Robust With 20+ GLP-1 Medications for Weight Loss:
Description
contributing to data analysis and interpretation

GLP-1 signaling reduces appetite and modulates reward, while GIP signaling enhances metabolic regulation and may have central nervous system effects
Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News

21 Myth : Taking GLP-1 drugs guarantees weight loss
10.1038/s41598-021-01912-0

Wegovy is also approved to lower the risk of adverse cardiovascular events and to treat a specific liver condition
